NewGenIvf Group Limited (NIVF)
USD 0.33
(-23.27%)
USD 0.33
(-23.27%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -857.35 Thousand | -527.12 Thousand | 1.43 Million |
| Net Income | -690.85 Thousand | 500.65 Thousand | -138.53 Thousand |
| Depreciation & Amortization | 229.7 Thousand | 303.94 Thousand | 342.53 Thousand |
| Deferred income taxes | - | 208.14 Thousand | - |
| Stock-based compensation | - | - | - |
| Change in working capital | 1.66 Million | -23.07 Thousand | 1.02 Million |
| Other non-cash items | -2.39 Million | -1.01 Million | 200 Thousand |
| Investing Cash Flow | 51.25 Million | -69.69 Million | -16.57 Thousand |
| Investments in PPE | -69.84 Thousand | -94.45 Thousand | -16.57 Thousand |
| Acquisitions | - | - | - |
| Investment purchases | -780 Thousand | -69.69 Million | - |
| Sales/Maturities of investments | 52.03 Million | - | - |
| Other Investing Activities | - | - | - |
| Financing Cash Flow | -50.4 Million | 70.27 Million | -1.54 Million |
| Debt repayment | -1.62 Million | -122.27 Thousand | -495.6 Thousand |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 192.3 Thousand | 71.86 Million | - |
| Other Financing Activities | -52.03 Million | -1.47 Million | -2.03 Million |
| Accounts receivables | 1166.00 | 129.92 Thousand | 56.18 Thousand |
| Accounts payables | 567.4 Thousand | 13.94 Thousand | -60.98 Thousand |
| Inventory | -80.66 Thousand | -7219.00 | 1352.00 |
| Other working capital | 1.09 Million | -37.01 Thousand | 812.15 Thousand |
| Cash at beginning of period | 54.71 Thousand | 28.76 Thousand | 106.19 Thousand |
| Cash at end of period | 42.22 Thousand | 54.71 Thousand | 28.76 Thousand |
| Capital Expenditure | -69.84 Thousand | -94.45 Thousand | -16.57 Thousand |
| Effect of forex changes on cash | -18.96 Thousand | 16.12 Thousand | 50.51 Thousand |
| Net cash flow / Change in cash | -12.49 Thousand | 25.95 Thousand | -77.42 Thousand |
| Free Cash Flow | -927.2 Thousand | -621.57 Thousand | 1.41 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -955.48 Thousand | -690.85 Thousand | 127.02 Thousand | 474.36 Thousand | 500.65 Thousand | 208.32 Thousand |
| Depreciation & Amortization | - | 229.7 Thousand | - | - | 303.94 Thousand | - |
| Deferred income taxes | - | - | - | - | 208.14 Thousand | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.12 Million | 1.66 Million | 173.75 Thousand | 81.96 Thousand | -23.07 Thousand | 83.35 Thousand |
| Other non-cash items | -333.88 Thousand | -2.39 Million | -655.61 Thousand | -591.04 Thousand | -1.01 Million | -314.37 Thousand |
| Investing Cash Flow | 18.37 Million | 51.25 Million | -248.28 Thousand | -241.79 Thousand | -69.69 Million | -18.82 Thousand |
| Investments in PPE | -4.38 | -69.84 Thousand | - | - | -94.45 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -61.02 Thousand | -780 Thousand | -270.46 Thousand | -241.79 Thousand | -69.69 Million | -18.82 Thousand |
| Sales/Maturities of investments | 18.43 Million | 52.03 Million | 22.18 Thousand | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -18.22 Million | -50.4 Million | 368.73 Thousand | 243.81 Thousand | 70.27 Million | 18.98 Thousand |
| Debt repayment | -207.18 Thousand | -1.62 Million | -390.91 Thousand | -424.24 | -122.27 Thousand | -33.03 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 192.3 Thousand | - | 249.35 Thousand | 71.86 Million | 19.41 Thousand |
| Other Financing Activities | -18.43 Million | -52.03 Million | -22.18 Thousand | -5120.26 | -1.47 Million | -398.65 |
| Accounts receivables | - | 1166.00 | - | - | 129.92 Thousand | - |
| Accounts payables | 19.72 Thousand | 567.4 Thousand | 151.56 Thousand | 49.37 | 13.94 Thousand | 3.77 |
| Inventory | - | -80.66 Thousand | - | - | -7219.00 | - |
| Other working capital | 1.1 Million | 1.09 Million | 22.18 Thousand | 81.91 Thousand | -37.01 Thousand | 83.34 Thousand |
| Cash at beginning of period | 38.75 Thousand | 54.71 Thousand | 121.56 Thousand | 87.37 Thousand | 28.76 Thousand | - |
| Cash at end of period | 42.22 Thousand | 42.22 Thousand | 38.75 Thousand | 54.71 Thousand | 54.71 Thousand | -22.54 Thousand |
| Capital Expenditure | -4.38 | -69.84 Thousand | - | - | -94.45 Thousand | - |
| Effect of forex changes on cash | - | -18.96 Thousand | - | - | 16.12 Thousand | - |
| Net cash flow / Change in cash | 3470.00 | -12.49 Thousand | -82.81 Thousand | -32.65 Thousand | 25.95 Thousand | -22.54 Thousand |
| Free Cash Flow | -142.7 Thousand | -927.2 Thousand | -203.27 Thousand | -34.67 Thousand | -621.57 Thousand | -22.7 Thousand |
WWL
BIOSGN
3073
300940
AHX
600845